Efficacy of Esketamine for Patients With Irritable Bowel Syndrome

Clinical trial NCT06788444 · RECRUITING

Trial details

NCT number: NCT06788444
Sponsor: Beijing Tiantan Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2025-09-18
Primary completion: 2026-12-31
Enrollment: 552

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.